Pages
Tier 3 Weight Management - Information for Patients
Information for patients about the Tier 3 Weight Management service in Derbyshire.
Weather alert: sub-zero temperatures, snow and ice warning
https://dchs.nhs.uk/news/weather-alert-sub-zero-temperatures-snow-and-ice-warning
Patient Group Directions (PGDs)
Patient Group Directions - PGDs provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a prescriber.
Improvement, Innovation and Effectiveness
Supporting colleagues to keep DCHS an outstanding place to work and recive care.
https://dchs.nhs.uk/about-us/quality-heart-our-care/improvement-innovation-effectiveness
Files
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024
8 Steps to Patient Isolation (L343)
Guidance to support colleagues when deciding how to isolate a patient with suspected/confirmed infection.